Cancer Progress Measures
View the objectives of this area of research.
In Press
Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman ME.
An overview of methods for monitoring social disparities in cancer with an example using trends in lung cancer incidence by socioeconomic position and race-ethnicty, 1992.
Am J Epidemiol
In Press.
2008
Simonetti A, Gigli A, Capocaccia R, Mariotto A.
Estimating complete prevalence of cancers diagnosed in childhood.
Stat Med
30 Mar 2008;27(7):990-1007.
2007
Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ.
Multiple cancer prevalence: a growing challenge in long-term survivorship.
Cancer Epidemiol Biomarkers Prev
Mar 2007;16(3):566-71.
Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, Warren JL.
Patient time costs associated with cancer care.
J Natl Cancer Inst
3 Jan 2007;99(1):14-23.
Yabroff KR, Mariotto AB, Feuer E, Brown ML. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. J Health Econ 2 Oct 2007 [Epub ahead of print].
Yabroff R, McNeel T, Waldron WR, Davis WW, Brown ML, Clauser S, Lawrence W.
Health limitations and quality of life associated with cancer and other chronic diseases by phase of care.
Medical Care
2007;45(7):629-637.
2006
Gigli A, Mariotto A, Clegg LX, Tavilla A, Corazziari I, Capocaccia R, Hachey M, Steve S.
Estimating the variance of cancer prevalence from population-based registries.
Stat Methods Med Res
Jun 2006;15(3):235-53.
Mariotto AB, Wesley MN, Cronin KA, Johnson KA, Feuer EJ.
Estimates of long-term survival for newly diagnosed cancer patients: a projection approach.
Cancer
1 May 2006;106(9):2039-50.
Mariotto AB, Yabroff KR, Feuer EJ, De Angelis R, Brown M.
Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020.
Cancer Causes Control
Dec 2006;17(10):1215-26.
Miller BA, Scoppa SM, Feuer EJ.
Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers.
Cancer
1 Feb 2006;106(3):670-82.
2005
Yabroff KR, Warren JL, Knopf K, Davis WW, Brown ML.
Estimating patient time costs associated with colorectal cancer care.
Med Care
Jul 2005;43(7):640-8.
2004
Centers for Disease Control and Prevention (CDC).
Cancer survivorship--United States, 1971-2001.
MMWR. Morbidity and mortality weekly report
25 Jun 2004;53(24):526-9.
Fay MP.
Estimating age conditional probability of developing disease from surveillance data.
Popul Health Metr
27 Jul 2004;2(1):6.
Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML.
Burden of illness in cancer survivors: findings from a population-based national sample.
J Natl Cancer Inst
1 Sep 2004;96(17):1322-30.
2003
Cronin KA, Feuer EJ, Wesley MN, Mariotto AB, Scoppa S, Green DT.
Current Estimates for 5 and 10 Year Relative Survival.
Statistical Research and Applications Branch, National Cancer Institute;
2003.
Technical Report # 2003-04.
Available at http://srab.cancer.gov/reports/.
Cronin KA, Mariotto AB, Scoppa S, Green DT, Clegg LX.
Differences Between Brenner et al. and NCI Methods for Calculating Period Survival.
Statistical Research and Applications Branch, National Cancer Institute;
2003.
Technical Report # 2003-02.
Available at http://srab.cancer.gov/reports/.
Fay MP.
Estimating age-conditional probablity of developing cancer using a piecewise mid-age joinpoint model for the rates.
Statistical Research and Applications Branch, National Cancer Institute;
2003.
Technical Report # 2003-03.
Available at http://srab.cancer.gov/reports/.
Fay MP, Pfeiffer R, Cronin KA, Le C, Feuer EJ.
Age-conditional probabilities of developing cancer.
Stat Med
15 Jun 2003;22(11):1837-48.
Mariotto A, Warren JL, Knopf KB, Feuer EJ.
The prevalence of patients with colorectal carcinoma under care in the U.S.
Cancer
15 Sep 2003;98(6):1253-61.
2002
Carr DB, Chen JX, Bell BS, Pickle LW, Zhang Y.
Interactive linked micromap plots and dynamically conditioned choropleth maps.
Proceedings of 2002 National Conference on Digital Government Research;
Los Angeles, California.
CM International Conference Proceeding Series; Vol. 129;
2002.
p. 61-68.
Clegg LX, Gail MH, Feuer EJ.
Estimating the variance of disease-prevalence estimates from population-based registries.
Biometrics
Sep 2002;58(3):684-8.
Fay MP, Pfeiffer R, Cronin KA, Le C, Feuer EJ.
Comparison of Two Methods for Calculating Age-Conditional Probabilities of Developing Cancer.
Statistical Research and Applications Branch, National Cancer Institute;
2002.
Technical Report #2002-01.
Available at http://srab.cancer.gov/reports/.
Mariotto A, Capocaccia R, Verdecchia A, Micheli A, Feuer EJ, Pickle L, Clegg LX.
Projecting SEER cancer survival rates to the US: an ecological regression approach.
Cancer Causes Control
Mar 2002;13(2):101-11.
Mariotto A, Gigli A, Capocaccia R, Clegg L, Scoppa S, Ries LA, Tesauro GS, Rowland JS, Feuer EJ.
Complete and Limited Duration Prevalence Estimates.
In:
SEER Cancer Statistics Review, 1973-1999.
Bethesda, MD:
National Cancer Institute;
2002.
Singh GK, Miller BA, Hankey BF, Feuer EJ, Pickle LW.
Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part I--All cancers among men.
J Natl Cancer Inst
19 Jun 2002;94(12):904-15.
U.S. Cancer Statistics Working Group.
United States Cancer Statistics: 1999 Incidence.
Atlanta, GA:
Department of Health and Human Services, Centers for Disease and Prevention and National Cancer Institute;
2002.
Available at http://www.cdc.gov/cancer/npcr/uscs/pdf/1999_USCS.pdf.
2001
Rowland JH, Aziz N, Tesauro G, Feuer EJ.
The changing face of cancer survivorship.
Semin Oncol Nurs
Nov 2001;17(4):236-40.
2000
Cronin KA, Feuer EJ.
Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
Stat Med
15 Jul 2000;19(13):1729-40.
Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, Edwards BK.
Partitioning linear trends in age-adjusted rates.
Cancer Causes Control
Jan 2000;11(1):31-5.
Merrill RM, Capocaccia R, Feuer EJ, Mariotto A.
Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Int J Epidemiol
Apr 2000;29(2):197-207.
1999
Merrill RM, Kessler LG, Udler JM, Rasband GC, Feuer EJ.
Comparison of risk estimates for selected diseases and causes of death.
Prev Med
Feb 1999;28(2):179-93.
Warren JL, Feuer E, Potosky AL, Riley GF, Lynch CF.
Use of Medicare hospital and physician data to assess breast cancer incidence.
Med Care
May 1999;37(5):445-56.
1998
Wun LM, Merrill RM, Feuer EJ.
Estimating lifetime and age-conditional probabilities of developing cancer.
Lifetime Data Anal
1998;4(2):169-86.
1997
Merrill RM, Weed DL, Feuer EJ.
The lifetime risk of developing prostate cancer in white and black men.
Cancer Epidemiol Biomarkers Prev
Oct 1997;6(10):763-8.
1996
Feuer EJ.
Lifetime probability of Cancer (Stat bite).
J Natl Cancer Inst
1996;89:279.
Merrill RM.
Stat Bite: Trends in Corpus Uteri Cancer Incidence .
J Natl Cancer Inst
1996;88:1019.
Merrill RM, Feuer EJ.
Risk-adjusted cancer-incidence rates (United States).
Cancer Causes Control
Sep 1996;7(5):544-52.
1994
Campbell MK, Feuer EJ, Wun LM.
Cohort-specific risks of developing breast cancer to age 85 in Connecticut.
Epidemiology
May 1994;5(3):290-6.
Chu KC, Miller BA, Feuer EJ, Hankey BF.
A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer.
J Clin Epidemiol
Dec 1994;47(12):1451-61.
1993
Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T.
The lifetime risk of developing breast cancer.
J Natl Cancer Inst
2 Jun 1993;85(11):892-7.
1992
Byrne J, Kessler LG, Devesa SS.
The prevalence of cancer among adults in the United States: 1987.
Cancer
15 Apr 1992;69(8):2154-9.
Feuer EJ, Wun LM, Boring CC.
Probability of developing cancer.
In:
Miller BA, Ries LA, Hankey BF, Kosary CL, Edwards BK, eds.
Cancer Statistics Review: 1973-1989.
National Cancer Institute, NIH pub.No.92-2789;
1992.
1990
Measurement of progress against cancer. Extramural Committee to Assess Measures of Progress Against Cancer.
J Natl Cancer Inst
16 May 1990;82(10):825-35.
1986
Feldman AR, Kessler L, Myers MH, Naughton MD.
The prevalence of cancer. Estimates based on the Connecticut Tumor Registry.
N Engl J Med
27 Nov 1986;315(22):1394-7.
|